Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the mecA Gene in Methicillin-Resistant Staphylococcus aureus: A Novel Approach to Reverse Antibiotic Resistance. (2026). Wah Academia Journal of Health and Nutrition, 2(2), 27-35. https://doi.org/10.63954/bantev40